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disease: A thematic edition
Graeme Rocker1, Morag Farquhar2,3
and Jennifer Verma4
Several years ago, and almost by chance, I attended an
early meeting of what would later become the
Cambridge-based Breathlessness Research Interest
Group. I found myself in the company of such lumin-
aries as Dr Sara Booth and Professor Irene Higginson
and colleagues in an atmosphere of exemplary intel-
lectual and clinical enquiry that I knew that I had, in
some ways, ‘‘come home.’’ Halifax, Nova Scotia, is
4600 km from Cambridge, England, and yet we sub-
sequently managed to forge a collaboration that
allowed for productive exchange visits. One such trip
led to my coauthor, Morag Farquhar, and her phy-
siotherapist colleague, Petrea Fagan (early key play-
ers in Sara Booth’s Breathlessness Intervention
Service (BIS)), presenting at Medical Grand Rounds
where the audience in Halifax heard for the first time
how a focused, patient-centered, home-based, and
multidisciplinary approach to the disabling symptom
of dyspnea could prove beneficial to patients, care-
givers, and the health system alike.
More than a decade on and I am delighted to be
able to introduce, with Morag, a series of manuscripts
for Chronic Respiratory Disease that will highlight
various initiatives under an umbrella of ‘‘new models
of care.’’ Two models (BIS, from Cambridge, and
INSPIRED, from Halifax) featured in a recent review
in the Canadian Medical Association Journal entitled
‘‘Palliative care for chronic illness: driving change.’’1
While our respective approaches and reach are differ-
ent, both programs are based on the fundamental pre-
mise that an understanding of patient and caregiver
need, and a multidisciplinary intervention that meets
that need, can have profoundly beneficial effects.
Evaluation has been key to the success of both mod-
els. We differ in that Cambridge (not unexpectedly)
took a more rigorous academic approach, developing
BIS through the Medical Research Council (MRC)
framework for complex interventions with early pilot
work, a pilot RCT, and subsequent more definitive
mixed-method RCT work.2–4 I was content to ride
on their coattails and take a more pragmatic quality
improvement approach with a heavy emphasis on
addressing existential distress. It was this approach
in Halifax that came to the attention of my other
coauthor, Jennifer Verma, at the Canadian Foundation
for Healthcare Improvement (CFHI), who was lead-
ing a chronic disease collaborative in Atlantic
Canada. INSPIRED’s mix of positive patient feed-
back and substantial and sustained reductions approx-
imately 60% in emergency visits and bed occupancy
for patients with advanced disease and previous heavy
facility reliance5 appealed to CFHI. Not only did
INSPIRED show the potential to contain costs for
health system administrators and policy makers, it did
it in a way that prioritized dignity of the patient and
their family and offered a coordinated approach to
care, provided in the comfort of home, inclusive of
dying at home if requested.6 Crisis aversion showed
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patients and families a ‘‘new possible.’’ A pan-
Canadian spread collaborative was born.5
There are always barriers to implementing a new
clinical service and those constructed by colleagues
shouldn’t be underestimated. After presenting the
INSPIRED model (in essence four educational/sup-
portive home visits shortly after a hospital admission
for an exacerbation of COPD), a senior UK physician
responded: ‘‘this couldn’t work here.’’ That kind of
‘‘perpetual uniqueness syndrome’’ in healthcare often
proves false, but, as a 2015 Canadian healthcare inno-
vation panel found, remains a predominant barrier to
spreading best practices:7
. . . even practical and definitive findings do not spark
widespread innovation in the absence of winning con-
ditions in the healthcare system. The frustrating reality
is that many excellent ideas or inventions are never
translated in saleable or scalable innovations.
In contrast, a ‘‘coalition of the willing’’ can over-
come barriers to successful spread and scale-up of an
effective initiative. The pan-Canadian INSPIRED
COPD collaborative supported 19 teams across
Canada, successfully adapting INSPIRED. The expe-
rience makes the point that champions, enthusiasm,
patient, and caregiver participation in design and
delivery of evidence-based practices in a feasible
approach within the community, coupled with
insightful investment in change,8 can triumph over
forces of negativity that pervade our traditional
healthcare systems. With more than 1000 patients
enrolled across Canada (as of September 2016 and
in addition to the *500 enrolled in Halifax), several
teams have already demonstrated similar outcomes to
the Halifax initiative, and over the next few months,
we will gather outcomes that matter both to patients
and to those with funding responsibilities.
The review series on ‘‘models of care’’ will pro-
vide illustrative examples of successful initiatives
playing out on two continents with contributions
from Canada, the United Kingdom, and Europe.
We thank the editors at Chronic Respiratory Disease
for the opportunity to proceed with this thematic
edition and hope the readership will find the series
of interest.
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